Log in | Register

Antimicrobial de-escalation in septic cancer patients: is it safe to back down?Open access

Alla Paskovaty| Stephen M. Pastores| Zivile Gedrimaite| Natalie Kostelecky| Elyn R. Riedel| Susan K. Seo
Letter
Volume 41, Issue 11 / November , 2015

Pages 2022 - 2023

No abstract available.

References

  1. Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, De-escalation Study Group (2015) Elaboration of a consensual definition of de-escalation allowing a ranking of beta-lactams. Clin Microbiol Infect 21:649.e1–649.e10. doi:10.1016/j.cmi.2015.03.013
    • View reference on publisher's website
  2. Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M (2014) De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 40:41–49
  3. Joung MK, Lee JA, Moon SY, Cheong HS, Joo EJ, Ha YE, Sohn KM, Chung SM, Suh GY, Chung DR, Song JH, Peck KR (2011) Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care 15:R79. doi:10.1186/cc10072
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement